Drug Type Small molecule drug |
Synonyms Capravirine (USAN/INN), capravirine + [1] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseSuspendedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20Cl2N4O2S |
InChIKeyYQXCVAGCMNFUMQ-UHFFFAOYSA-N |
CAS Registry178979-85-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03371 | Capravirine | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 3 | US | - | |
HIV Infections | Phase 3 | - | - | |
HIV Infections | Phase 3 | - | - | |
HIV Infections | Phase 3 | - | - | |
HIV Infections | Phase 3 | US | - | |
HIV Infections | Phase 3 | US | - | |
HIV Infections | Phase 3 | - | - | |
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | - | - |
Not Applicable | 615 | obbfibkino(bbqtufknvy) = pihodxmida jztomrfakg (cnvvwgnwtf ) | - | 01 Jan 2002 |